Bayer Aktiengesellschaft (BAYRY)
| Market Cap | 27.15B |
| Revenue (ttm) | 50.53B |
| Net Income (ttm) | -3.35B |
| Shares Out | 3.93B |
| EPS (ttm) | -3.41 |
| PE Ratio | n/a |
| Forward PE | 5.12 |
| Dividend | $0.03 (0.43%) |
| Ex-Dividend Date | Apr 29, 2024 |
| Volume | 52,088 |
| Open | 6.93 |
| Previous Close | 6.98 |
| Day's Range | 6.90 - 6.95 |
| 52-Week Range | 6.89 - 14.70 |
| Beta | 0.95 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 27, 2024 |
About BAYRY
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter med... [Read more]
News
Bayer and Rad AI Announce Collaboration agreement
NATIONAL HARBOR, Md.--(BUSINESS WIRE)--As experts from around the globe gather at the annual Society for Informatics in Medicine (SIIM) conference, Bayer and Rad AI are announcing a collaboration to b...
Bayer's pharmaceutical unit plans more managerial cuts in Europe, Asia
A top Bayer pharmaceutical executive said on Wednesday his group will continue slashing managerial jobs this year, planning cuts in Germany, Japan, the United Kingdom, Belgium and the Netherlands as p...
Bayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets
WAGENINGEN, Netherlands--(BUSINESS WIRE)--Bayer and Solynta have reached an agreement to collaborate on the commercialization and distribution of true potato seeds in Kenyan and Indian markets. This p...
Bayer looks to AI to combat herbicide resistance faster
Bayer's crop science division is increasingly turning to artificial intelligence in its battle against crop killing weeds, the company told Reuters.
Judge cuts Bayer $2.25 billion Roundup verdict to $400 million
A Pennsylvania judge on Tuesday slashed a $2.25 billion U.S. verdict against Bayer to $400 million for a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller...
Bayer, maker of Roundup weedkiller, steps up fight against cancer-related lawsuits
JEFFERSON CITY, Mo. — After failing in several U.S. states this year, global chemical manufacturer Bayer said Tuesday that it plans to amplify efforts to create a legal shield against a proliferation ...
Bayer presents latest data from oncology portfolio at 2024 ASCO Annual Meeting
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present new data across its oncology portfolio at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago, from Ma...
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
BERLIN--(BUSINESS WIRE)--Bayer announced today initiation of dosing in a Phase I first-in-human clinical study with 225Ac-PSMA-Trillium (BAY 3563254), a next-generation targeted alpha therapy. The inv...
Bayer's Q1 adjusted profit beats analyst consensus
Bayer on Tuesday reported a 1.3% decline in adjusted earnings in the first quarter, beating analysts' forecasts on better-than-expected performance at its prescription drugs and agriculture divisions.
Study Design and Baseline Characteristics of Prespecified, Exploratory Pooled Analysis to Investigate Effect of Finerenone on Cardio-Kidney Outcomes in Patients with CKD and Type 2 Diabetes and/or Heart Failure Shared at Heart Failure 2024 Congress
WHIPPANY, N.J.--(BUSINESS WIRE)--The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled analysis of three Phase III trials with finerenone1, were presented...
Bayer to Present Investigational Data from Comprehensive KERENDIA® (finerenone) Clinical Trial Program at Heart Failure 2024 Congress
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer will present Kerendia® (finerenone) data from its comprehensive clinical trial program in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in...
WomenHeart and Bayer Join Forces to Enhance Heart Health Awareness and Education Among Women Across the U.S.
WASHINGTON--(BUSINESS WIRE)--WomenHeart: The National Coalition for Women with Heart Disease, in collaboration with Bayer, is proud to announce the launch of the Understanding Her Heart: Women and Car...
Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopause
BERLIN--(BUSINESS WIRE)--Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2, evaluating the efficacy and safety of the investigational compound elinzanetant versus pl...
FourKites, Bayer and Graphic Packaging International to Present at Gartner Supply Chain Symposium/Xpo 2024
CHICAGO--(BUSINESS WIRE)--Leading real-time supply chain visibility provider FourKites today announced that it will join Bayer and Graphic Packaging International in two separate tracks at the upcomin...
Bayer and Evotec Collaborate to Advance Precision Cardiology
BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASES STRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETS J...
Bayer CEO wins first AGM shareholder vote
Bayer CEO Bill Anderson on Friday won a vote of confidence at his first annual general meeting (AGM) at the helm of the embattled healthcare and agriculture group, defying a challenge from one German ...
Bayer investor Deka takes a stand against CEO in annual vote
Bayer shareholder Deka Investment said on Friday it would not join other large investors in supporting the healthcare and agriculture group's management at its annual general meeting.
Bayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues.
Bayer confirms outlook despite slow businesses in agriculture, consumer health
Bayer on Monday confirmed its full-year guidance for earnings and cash flow despite slow business at its crop science and consumer health divisions.
Bayer's patent for blood thinner Xarelto invalid, UK court rules
Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker.
Bayer and Google Cloud to accelerate development of AI-powered healthcare applications for radiologists
LAS VEGAS--(BUSINESS WIRE)--Bayer and Google Cloud today announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve pati...
Bayer's Consumer Health Division Announces Changes to North America Leadership Team
WHIPPANY, N.J.--(BUSINESS WIRE)--Today, Bayer announced Samantha Avivi as the new Chief Marketing Officer (CMO) for its Consumer Health division in North America. She will report directly to Dave Toma...
Google partners with Bayer on new AI product for radiologists
Google Cloud and Bayer are building a new AI-powered platform to help radiologists work more efficiently.
Judge slashes Bayer $1.56 billion Roundup verdict to $611 million
A Missouri judge slashed a $1.56 billion verdict against Bayer to $611 million for three people who claimed its Roundup weed killer caused their cancer, by reducing punitive damages. Bayer said on Fri...
Federman & Sherwood Investigates Bayer Heritage Federal Credit Union for Data Breach
OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Investigates Bayer Heritage Federal Credit Union for Data Breach.